Novartis gets EU OK for new flu vaccine
505570
Novartis AG has received European Union approval for flu vaccine Optaflu, the Swiss drugmaker said Wednesday.
57824
The government is purchasing as many as 5 million additional doses of flu vaccine from plants in Canada and Germany to help relieve the US shortage.
18076
The federal government is purchasing additional doses of flu vaccine from a foreign manufacturer to help relieve the US shortage. Up to 5 million doses are available from plants in Canada and Germany, but
176923
WASHINGTON Dec 6, 2004 - The government is purchasing additional doses of flu vaccine from a foreign manufacturer to help relieve the US shortage.
612454
Sept. 24, 2004 -- An FDA advisory committee has recommended licensure for a new meningitis vaccine called Menactra. According to its maker, Sanofi-Aventis Group, the vaccine was shown to be safe and well tolerated.
129481
MedImmune Inc. will provide an additional 1 million doses of its FluMist nasal-spray vaccine this year to help the country overcome a shortage of flu shots, US health officials said yesterday.
112756
Merck & Co Inc's Gardasil, the first   vaccine to prevent cervical cancer, has been approved for sale   in the Europe Union, the joint venture that will market the   product in Europe said on Friday.
492501
The biopharmaceutical company removes some uncertainty by teaming up with Novartis.
432403
The European Commission said Monday it has approved two vaccines to be used against the bird flu virus in the EU member states. The vaccines, the first to be approved by the EU executive, are Nobilis Influenza H5N2, for use in chickens, and Poulvac FluFend H5N3 RG, for use in both chickens and Pekin ducks, the most common breed of duck used for commercial meat.
383061
A panel of US experts on Wednesday unanimously agreed that a new Sanofi-Aventis meningitis vaccine has been shown to be safe and effective, but said follow-up data was needed.
156827
The drugmaker Novartis AG said Monday that the European Commission had approved its Exelon skin patch to treat Alzheimer's disease.
186568
Pharmaceutical group Novartis said on Monday it had received U.S. approval for Exelon Patch, which delivers a treatment for Alzheimer's disease through a skin patch instead of an oral capsule.
60176
A first-generation experimental bird flu vaccine for use in humans from GlaxoSmithKline Plc has won outline support from European regulators.
606882
While patients are panicking over a shortage of flu vaccine in the United States, vaccination programs in Europe are progressing smoothly.
639682
MedImmune said last week that it has resolved problems with the manufacturing of its nasal flu vaccine FluMist, clearing the way for the Food and Drug Administration to allow the company to ship the product in time for flu season.
158030
U.S. health officials on Tuesday  approved the importation of up to 4 million doses of influenza  vaccine made by GlaxoSmithKline, bringing the U.S. total to 65  million vaccines for this flu season.
165412
Enablex, also known as darifenacin, was approved by the Food and Drug Administration. Novartis (nyse: NVS - news - people ) had purchased the drug from Pfizer (nyse: PFE - news - people ) for $225 million